TFQI-fT3
1 paper2 findings
- Humans1
Associations
2Abnormal ST segments
downin humans1OR 0.57
1 study
Abnormal ST segments
downin humans1OR 0.57
TFQI-fT3 lowers the risk of abnormal ST segments in humans (OR 0.57, 95% CI 0.32-0.97).
Humansyounger adults
Frontiers in endocrinology9 Sep 2026
Metabolic syndrome
downin humans1OR 0.79
1 study
Metabolic syndrome
downin humans1OR 0.79
TFQI-fT3 lowers the risk of metabolic syndrome in humans (OR 0.79, 95% CI 0.65-0.97).
Humansolder adults (>48 years)
Frontiers in endocrinology9 Sep 2026
Latest
1 in 12 monthsFrontiers in Endocrinology
Age-related changes in HPT axis sensitivity and their associations with metabolic and cardiovascular health: a cross-sectional, Chinese nationwide study
Cross-sectional study of 13,646 peopleMechanisms